As such, an aptamer against transferrin receptor (TfR), which is often over-expressed in various solid tumors, was used to deliver the precursor of miRNA-126 (pre-miR-126) to breast cancer cells, and this chimera was found to significantly reduce the proliferation and paracrine endothelial cell recruitment of breast cancer cells [121]. The gene discussed is TFRC; the disease is breast cancer.